North China Pharma integrates R&D strength in its system

North China Pharmaceutical Company (NCPC) faced a decline of around 26 percent in 2012. The company is principally eng...

June 3, 2013 | Monday | Analysis
Asia faces an acute skills gap challenge

Shortage of skills and qualification among life science professionals to pursue risk laden activities is proving to be a...

June 12, 2013 | Wednesday | Analysis
Mindray goes on acquisition spree for strong portfolio

Mindray Medical International is emerging as a global name in the medical devices industry, marking 25 percent growth in...

June 22, 2012 | Friday | Analysis
Resmed dominates the niche sleep disorder market

A distinguished name in treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disor...

June 4, 2013 | Tuesday | Analysis
Sinopharm demonstrates king size growth, yet again

Sinopharm, a dominant name in the distribution of pharmaceutical and healthcare products in China, continues to grab a...

May 31, 2013 | Friday | Analysis
Cipla nurtures global vision for affordable drugs

The king of generics, Cipla, has been aggressive in expanding product portfolio and reaching out to international market...

June 13, 2012 | Wednesday | Analysis
Asia bioscience grows 11 percent, crosses $150 bn

During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording ...

June 21, 2013 | Friday | Analysis
Dr. Reddy's makes a mark in the US generics market

Striking profit on a high note, Dr. Reddy's crossed $1.5 billion worth of business in 2012, marking a growth of 22 per...

June 4, 2013 | Tuesday | Analysis
Aurobindo Pharma revamps strategy to accelerate growth

Aurobindo Pharma, ranked among the top pharmaceutical company in India, clocked $1 billion revenue in 2012. Aurobindo ...

June 4, 2013 | Tuesday | Analysis
ResMed builds on partnerships for growth

Driving in the niche industry of sleep disorders, ResMed was aggressive in strengthening its portfolio through acquisiti...

June 14, 2012 | Thursday | Analysis
Bioscience Industry clocks $139 bn, grows 8.37%

The bioscience industry in the Asia Pacific region, in 2011, got pulled back into a low growth cycle. In a replay of 200...

July 3, 2012 | Tuesday | Analysis
Sigma Pharma leverages on its pharmacy business

Marking a strong presence of 100 years in the pharmaceutical sector in the year 2012, Sigma Pharmaceuticals retained i...

May 31, 2013 | Friday | Analysis
Shenzhen Neptunus invests in drug innovation

Shenzhen Neptunus Bioengineering is a well-recognized name in manufacturing and distribution of pharmaceutical product...

June 4, 2013 | Tuesday | Analysis
China holds largest pharma revenue share in APAC

In 2011, China maintained its top position in the Asia Pacific's region for pharmaceutical industry, with the largest sh...

June 11, 2012 | Monday | Analysis
China secures rank 1 in terms of total company revenues

China emerged as the third country in terms of the total revenue generated by companies during the calendar year 2012 in...

June 18, 2013 | Tuesday | Analysis
China, Australia dominate APAC pharma market

The pharmaceutical market in several nations of the Asia Pacific (APAC) region witnessed a significant growth during 201...

June 11, 2012 | Monday | Analysis
China National Accord's R&D strategy begins to pay-off

China National Accord Medicines Corporation utilized 2012 as a year to speed up the transformation and upgrade scienti...

May 31, 2013 | Friday | Analysis
India's 127-year-old ayurvedic leader clocks $847 mn

Growing on its legacy of 127 years, Dabur India clocked $847 million in 2012. The company is recognized for manufactur...

June 4, 2013 | Tuesday | Analysis